Variation in the ordered structure of complexes between CD154 and anti-CD154 monoclonal antibodies

被引:12
作者
Ferrant, JL
Wilson, CA
Benjamin, CD
Hess, DM
Hsu, YM
Karpusas, M
Roux, KH
Taylor, FR
机构
[1] Biogen Inc, Cambridge, MA 02142 USA
[2] Florida State Univ, Dept Biol Sci, Struct Biol Program, Tallahassee, FL 32306 USA
关键词
CD154; CD40L; TNF ligand family; immune complexes;
D O I
10.1016/S0161-5890(02)00045-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cell surface co-stimulatory protein CD154 (CD40L) is a target for monoclonal antibody (mAb) inhibitors of T-cell mediated immune diseases. This protein, like most other members of the TNF ligand family, forms homotrimeric complexes on the cell surface and in solution, with a three-fold axis of symmetry. We find that several different anti-CD154 monoclonal antibodies form distinctive complexes with soluble CD154. These soluble complexes have been analyzed using size exclusion chromatography, static and dynamic light scattering, and electron microscopy and shown to consist of caged structures of various geometries. The cell surface complexes have been analyzed by confocal microscopy and, depending on the mAb, remain as small, separate complexes or form large aggregates. The formation of these complexes in solution is likely to have an impact on measures of affinity, while the cell surface complexes could affect binding potency and provoke other biological effects. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 24 条
[1]   The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation [J].
Brenner, B ;
Koppenhoefer, U ;
LeppleWienhues, A ;
Grassme, H ;
Muller, C ;
Speer, CP ;
Lang, F ;
Gulbins, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (01) :11-17
[2]   Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes [J].
Brenner, B ;
Koppenhoefer, U ;
Grassme, H ;
Kun, J ;
Lang, F ;
Gulbins, E .
FEBS LETTERS, 1997, 417 (03) :301-306
[3]  
Burkly LC, 2001, ADV EXP MED BIOL, V489, P135
[4]  
Clark LB, 1996, ADV IMMUNOL, V63, P43
[5]   SEGMENTAL FLEXIBILITY AND COMPLEMENT-FIXATION OF GENETICALLY ENGINEERED CHIMERIC HUMAN, RABBIT AND MOUSE ANTIBODIES [J].
DANGL, JL ;
WENSEL, TG ;
MORRISON, SL ;
STRYER, L ;
HERZENBERG, LA ;
OI, VT .
EMBO JOURNAL, 1988, 7 (07) :1989-1994
[6]   CLONING OF TRAP, A LIGAND FOR CD40 ON HUMAN T-CELLS [J].
GRAF, D ;
KORTHAUER, U ;
MAGES, HW ;
SENGER, G ;
KROCZEK, RA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) :3191-3194
[7]   Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes [J].
Hsu, YM ;
Lucci, J ;
Su, LH ;
Ehrenfels, B ;
Garber, E ;
Thomas, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :911-915
[8]   2 ANGSTROM CRYSTAL-STRUCTURE OF AN EXTRACELLULAR FRAGMENT OF HUMAN CD40 LIGAND [J].
KARPUSAS, M ;
HSU, YM ;
WANG, JH ;
THOMPSON, J ;
LEDERMAN, S ;
CHESS, L ;
THOMAS, D .
STRUCTURE, 1995, 3 (10) :1031-1039
[9]   Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody [J].
Karpusas, M ;
Lucci, J ;
Ferrant, J ;
Benjamin, C ;
Taylor, FR ;
Strauch, K ;
Garber, E ;
Hsu, YM .
STRUCTURE, 2001, 9 (04) :321-329
[10]   The CD40-ligand stimulates T-lymphocytes via the neutral sphingomyelinase: A novel function of the CD40-ligand as signalling molecule [J].
Koppenhoefer, U ;
Brenner, B ;
Lang, F ;
Gulbins, E .
FEBS LETTERS, 1997, 414 (02) :444-448